American Ebola doctor: 'I am thrilled to be alive'
Kent Brantly and his fellow medical missionary, Nancy Writebol, who was quietly discharged two days earlier, are still weak but should recover completely, and no one need fear being in contact with them, said Bruce Ribner, who runs the infectious-disease unit at Emory University Hospital.
Brantly's reappearance was festive and celebratory, a stark contrast to his arrival in an ambulance under police escort three weeks earlier, when he shuffled into the hospital wearing a bulky white hazardous-materials suit.
"I am thrilled to be alive, to be well, and to be reunited with my family," Brantly said, choking up as he read a written statement. Then he and his wife turned and greeted a parade of doctors and nurses, hugging or shaking hands with each one. For some, it was their first direct contact without protective gear.
Working connections, they obtained one of only five courses available worldwide of an experimental drug known as Zmapp, and Brantly and Writebol split the doses before being evacuated to Atlanta. The other four were later given to a Spanish priest, who died, and three medical workers in Africa, who have been improving.
Writebol's son, Jeremy Writebol, of Wichita, Kan., spent two weeks at the hospital with her but he left Tuesday morning.
"I haven't given her a hug yet, I am anxious to do that, but we are waiting for the right time and for her to be able to be with us," he said in a telephone interview.
His mother is able to move around, eat, and drink normally. "It is better than what she expected," he said, adding that his parents are considering their next steps.
Brantly didn't take questions at the news conference, but he did briefly describe how they confronted Ebola in Liberia. He said aid workers had begun "preparing for the worst" after learning of the outbreak in March, and saw their first patient in June. Soon, many more arrived.
He said his team took all the precautions they could. After his wife and children returned to the United States for a family wedding, he focused on work, moving patients to a bigger isolation unit. Three days later, he woke up feeling sick, and was diagnosed with the disease.
"As I lay in my bed in Liberia for the following nine days, getting sicker and weaker each day, I prayed that God would help me to be faithful even in my illness," Brantly said. "Through the care of the Samaritan's Purse and SIM missionary team in Liberia, the use of an experimental drug, and the expertise and resources of the health-care team at Emory University Hospital, God saved my life."
His doctors cautioned that it's unclear whether the drug or a blood transfusion Brantly got from a young Ebola survivor in Africa was helpful.
"Experimental means exactly that. They are the very first individuals to have received this treatment and frankly we do not know," Ribner said.
Brantly and Writebol were discharged after their medical team made sure they would not infect others. Their blood tested clean of the virus, which is spread only through direct contact with the bodily fluids of sick people experiencing symptoms. Ebola survivors generally are not contagious once they have recovered.
Both families asked for time alone to recover fully. David Writebol said in a statement that his wife is recuperating at an undisclosed location.
The survivors are not saying what they will do next. Ribner said there's no concern of a relapse, "and in fact we would anticipate immunity from this virus if they were treating patients during this outbreak."
There is a huge gap between the topflight care these Americans got at Emory, where a crew of five infectious-disease experts and 21 nurses provided rigorous care, and West Africa, where the virus has killed more than 1,300 people and counting, and even such basics as sterile fluids can be in short supply.
Ribner said he has "no clue how much they might have spent" saving the missionaries' lives, but he insisted that bringing them to Atlanta "was the right decision."
Liberians Said To Be Improving
Two Liberian health-care workers who received experimental medication to fight the Ebola virus have shown some improvement, the World Health Organization said Thursday.
The health agency said that doctors working in Liberia told them a doctor and nurse have shown "marked improvement" after receiving the drug ZMapp.
A second doctor being treated with the drug in Liberia remained in serious condition, the statement said, but "has improved somewhat."
The survival rate for patients infected with Ebola in the current outbreak stands at about 50 percent.
- Los Angeles Times